1-1 of 1 results for subject:AstraZeneca
Librarians' tools
- Search time
- 0.135 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:AstraZeneca
- We searched for
- subject_t:AstraZeneca OR subject_ses:2690
Type
House
Session
Year
Department
Member
Primary member
Answering member
More
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 9 December 2022 to Question 95901 on Development Aid: Vaccination, for what reason the estimate of £3.36 per dose was the best available at the time the statistics on vaccine donations were compiled;...
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 9 December 2022 to Question 95901 on Development Aid: Vaccination, for what reason the estimate of £3.36 per dose was the best available at the time the statistics on vaccine donations were compiled;...
The estimate of £3.36 per dose was the best available at the time the statistics on vaccine donations were compiled, as the overall cost to Astrazeneca of developing the vaccinations had not been finalised. Only when all Astrazeneca's expenditures have been taken into account can the final price per dose be reconciled to ensure, as per the contract, that there is no profit and no loss. This reconciliation has now started with the aim to finalise the cost per dose by the end of the 2022/2023 financial year. We will update the final price per date in line with the revisions policy (https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1021440/FCDO-Revisions-Policy.pdf).